Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20003375HPVENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TVIS20006860HPVENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TVIS44022560HTLV-1ENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TVIS44022561HTLV-1ENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TVIS44050516HTLV-1ENSG00000204681.11protein_codingGABBR1NoNo2550Q5SUJ9
Q8IW08
Q9UBS5
TCGA Plot Options
Drug Information
GeneGABBR1
DrugBank IDDB01956
Drug NameTaurine
Target IDBE0000217
UniProt IDQ9UBS5
Regulation Typeagonist
PubMed IDs29123472
CitationsKilb W, Fukuda A: Taurine as an Essential Neuromodulator during Perinatal Cortical Development. Front Cell Neurosci. 2017 Oct 24;11:328. doi: 10.3389/fncel.2017.00328. eCollection 2017.
GroupsApproved; Nutraceutical
Direct ClassificationOrganosulfonic acids
SMILESNCCS(O)(=O)=O
PathwaysCongenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; Taurine and Hypotaurine Metabolism; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX)
PharmGKBPA451590
ChEMBLCHEMBL239243